Literature DB >> 19119020

Transfusion after shoulder arthroplasty: an analysis of rates and risk factors.

Konrad I Gruson1, Kenneth J Accousti, Bradford O Parsons, Gita Pillai, Evan L Flatow.   

Abstract

HYPOTHESIS: Advancing age, lower preoperative hemoglobin levels, and more complex procedures are risk factors in transfusion requirements following shoulder arthroplasty.
MATERIALS AND METHODS: We retrospectively reviewed the records of 196 consecutive shoulder arthroplasties performed by a single surgeon (including 113 primary noncomplex total shoulder arthroplasties, 27 primary noncomplex hemiarthroplasties, 37 revision or complex arthroplasties, and 19 reverse shoulder arthroplasties). Logistic regression analysis was used to determine which clinical variables were associated with the need for postoperative transfusion.
RESULTS: The overall transfusion rate was 43% (84/196). The presence of preoperative anemia (males <13 g/dl, females <12 g/dl), decreasing preoperative hemoglobin levels, female gender, increasing age, and implantation of a reverse shoulder arthroplasty were independent risk factors for postoperative transfusion. Operative time, estimated blood loss, anesthesia type, preoperative use of anticoagulants and body mass index (BMI) were not found to be predictive of transfusion. DISCUSSION: Our results corroborate the few existing studies regarding the effects of lower preoperative hemoglobin levels on transfusion risk following shoulder arthroplasty. In contrast to these studies, however, we found increasing age and the implantation of a reverse shoulder arthroplasty to be independent predictors for transfusion.
CONCLUSION: The results of the present study support close postoperative monitoring of older, female patients (>65 years), patients with preoperative anemia (males <13 g/dl, females <12 g/dl), and those undergoing reverse shoulder replacement. These patients should be educated before surgery of the potential need for postoperative blood transfusion. LEVEL OF EVIDENCE: Level 4; Retrospective case series, no control group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19119020     DOI: 10.1016/j.jse.2008.08.005

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  32 in total

1.  Total shoulder arthroplasty in older patients: increased perioperative morbidity?

Authors:  Eric T Ricchetti; Joseph A Abboud; Andrew F Kuntz; Matthew L Ramsey; David L Glaser; Gerald R Williams
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

2.  What Are Risk Factors for 30-day Morbidity and Transfusion in Total Shoulder Arthroplasty? A Review of 1922 Cases.

Authors:  Chris A Anthony; Robert W Westermann; Yubo Gao; Andrew J Pugely; Brian R Wolf; Carolyn M Hettrich
Journal:  Clin Orthop Relat Res       Date:  2014-12-19       Impact factor: 4.176

3.  Drain Use is Associated with Increased Odds of Blood Transfusion in Total Shoulder Arthroplasty: A Population-Based Study.

Authors:  Jimmy J Chan; Carl M Cirino; Hsin-Hui Huang; Jashvant Poeran; Madhu Mazumdar; Bradford O Parsons; Shawn G Anthony; Leesa M Galatz; Paul J Cagle
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

4.  Differences in total blood loss and transfusion rate between different indications for shoulder arthroplasty.

Authors:  Dominik Malcherczyk; Juliane Hack; Antonio Klasan; Asma Abdelmoula; Thomas J Heyse; Brandon Greene; Bilal F El-Zayat
Journal:  Int Orthop       Date:  2018-08-03       Impact factor: 3.075

5.  Total Shoulder Arthroplasty: Is Less Time in the Hospital Better?

Authors:  Kyle R Duchman; Chris A Anthony; Robert W Westermann; Andrew J Pugely; Yubo Gao; Carolyn M Hettrich
Journal:  Iowa Orthop J       Date:  2017

6.  Tranexamic Acid in Shoulder Arthroplasty. A Comprehensive Review.

Authors:  Christos Koutserimpas; Georgios Th Besiris; Dimitrios Giannoulis; Konstantinos Raptis; Konstantinos Vlasis; Konstantinos Dretakis; Kalliopi Alpantaki
Journal:  Maedica (Bucur)       Date:  2021-03

7.  Conversion of stemmed hemi- or total to reverse total shoulder arthroplasty: advantages of a modular stem design.

Authors:  Karl Wieser; Paul Borbas; Eugene T Ek; Dominik C Meyer; Christian Gerber
Journal:  Clin Orthop Relat Res       Date:  2014-10-07       Impact factor: 4.176

8.  Can Surgeons Adequately Capture Adverse Events Using the Spinal Adverse Events Severity System (SAVES) and OrthoSAVES?

Authors:  Brian P Chen; Katie Garland; Darren M Roffey; Stephane Poitras; Geoffrey Dervin; Peter Lapner; Philippe Phan; Eugene K Wai; Stephen P Kingwell; Paul E Beaulé
Journal:  Clin Orthop Relat Res       Date:  2016-08-10       Impact factor: 4.176

9.  Blood transfusion rates following shoulder arthroplasty in a high volume UK centre and analysis of risk factors associated with transfusion.

Authors:  P J Dacombe; J V Kendall; Pas McCann; I N Packham; P P Sarangi; M R Whitehouse; M A Crowther
Journal:  Shoulder Elbow       Date:  2018-05-14

10.  Tranexamic acid use is associated with lower transfusion rates in shoulder arthroplasty patients with preoperative anaemia.

Authors:  T Bradly Clay; A Sayo Lawal; Thomas W Wright; Matthew Patrick; Aimee M Struk; Kevin W Farmer; Joseph J King
Journal:  Shoulder Elbow       Date:  2019-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.